cartouche ECN WORKSHOP
-

Abstracts

2023 - Poster

Therapeutics-Miscellaneous

Treatment of gout patients in seven primary care centers from Barcelona

Cesar Diaz-Torne (1), Daniel Martinez-Laguna (2), Raquel Gayarre (3), Meritxell Aivar (4), Jordi Hoyo (5), Angeles Conesa (2), Carlen Reyes (6), Cristina Carbonell (7), Jose Luis Estebanez (8), Maria Antonia Pou (3)

2015 - Poster

Therapeutics-Miscellaneous

How the appearance of tophi changes ultrasonographic parameters independently associated with cardiovascular risk.

R. Gancheva (1), A. Kundurdjiev (2), M. Ivanova (1), T. Kundurzhiev (3), R. Rashkov (1), Z. Kolarov (1)

2021 - Oral communication

Therapeutics-Miscellaneous

Effect of leflunomide on pegloticase response rate in patients with uncontrolled gout

Karim Richard Masri (1), Kevin Winterling (1), Brian Lamoreaux (2)

2015 - Poster

Therapeutics-Miscellaneous

Gout - A consequence of multimorbidity impacts heavily on patients’ health.

Ankli B. (1), Kyburz D. (2), Hirschmann A. (3), Studler U. (4), Heijnen I. (5), Daikeler T. (6)

2018 - Poster

Therapeutics-Miscellaneous

Anakinra for calcium pyrophosphate crystal arthritis: an efficient, safe alternative treatment

Marine Forien, Marion Thomas, Elisabeth Palazzo, Philippe Dieudé, Sébastien Ottaviani

2020 - Poster

Therapeutics-Miscellaneous

Key role of the Clinical Nurse Specialist in patients with gout: results of a quality-of-care survey

E. Calvo-Aranda, FM. Sanchez-Aranda, L. Cebrian-Mendez, MA. Matias De La Mano, L. Lojo-Oliveira, MT. Navio-Marco

2019 - Oral communication

Therapeutics-Miscellaneous

The first phase 2a proof-of-concept study of a selective NLRP3 inflammasome inhibitor, dapansutrile™ (OLT1177™), in acute gout

T. L. Jansen (1), V. Klück (2), M. Janssen (1), A. Comarniceanu (1), M. Efdé (1), C. L. Scribner (3), R. B. Barrow (3), D. B. Skouras (3), C. A. Dinarello (3,4), L.A.B. Joosten (2)

2018 - Poster

Therapeutics-Miscellaneous

Efficacy and tolerance of sodium thiosulfate injection in calcific tendinopathy of the rotator cuff

Christelle Darrieutort-Laffite, Thomas Garraud, Axelle Bertrand-Vasseur, Benoît Le Goff

2018 - Oral communication

Therapeutics-Miscellaneous

Determining role of joint ultrasonography in patients with gout starting treatment with febuxostat

Marta Novella, Enrique Calvo, Tamara Rodríguez, J.L. Cabrera, Jorge Juan González, Francisco Aramburu, Carolina Marín, Ana Gómez, Patricia Alcocer, Irène Amil, Marta Valero, Silvia Rodríguez, Paloma García De La Peña.

2021 - Oral communication

Therapeutics-Miscellaneous

Microglia control small vessel calcification via TREM2

Yvette Zarb (1) , Sina Nassiri (2), Sebastian Guido Utz (3), Johanna Schaffenrath (1), Mauro Delorenzi (2), Marco Colonna (4), Melanie Greter (3), Annika Keller(1)

2021 - Oral communication

Therapeutics-Miscellaneous

Effect of metformin on clinical gout outcomes in gout patients with diabetes mellitus

F. Veenstra (1), Lm. Verhoef (1), M. Opdam (1), Aa. Den Broeder (1,3), W. Kwok (2), I. Meek (3, Fhj. Van Den Hoogen (1,3), M. Flendrie (1), N. Van Herwaarden (1,3)

2021 - Oral communication

Therapeutics-Miscellaneous

Outcomes of care among patients with gout in europe: a cross-sectional survey

Ritch Te Kampe (1,2), Tim L. Jansen (2), Caroline Van Durme (1), Matthijs Janssen (2), Gudula Petersen (3), Annelies Boonen (1)

2015 - Poster

Therapeutics-Miscellaneous

Serum magnesium levels in patients in relation to diuretic treatment

Irati Urionagüena, Sandra P. Chinchilla, Fernando Perez-Ruiz.